Skip to main content

Institutional Biosafety Committee

Medical Background with Various Cells

The Institutional Biosafety Committee (IBC) oversees all research involving biological materials including some molecules, bacteria, viruses, arthropods and recombinant DNA technology in accordance with guidance from the National Institutes of Health (NIH). In addition, if you are creating transgenic lines of organisms as research models, they could require approval from IBC.

Next IBC Meeting: November 16, 2022; 10am-12pm

For location information, contact the IBC

To report compliance issues, call EthicsPoint Hotline toll free 1-955-236-1443.

  • Erica Martin – Senior Compliance Specialist           



  • Kaitlin GottusoDirector